Cargando…

Gadoxetic acid-enhanced MRI combined with T1 mapping and clinical factors to predict Ki-67 expression of hepatocellular carcinoma

OBJECTIVES: To explore the predictive value of gadoxetic acid-enhanced magnetic resonance imaging (MRI) combined with T1 mapping and clinical factors for Ki-67 expression in hepatocellular carcinoma (HCC). METHODS: A retrospective study was conducted on 185 patients with pathologically confirmed sol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Ganbin, Chen, Jincan, Liao, Weixiong, Liu, Yonghui, Wen, Zhongyan, Zhao, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348748/ https://www.ncbi.nlm.nih.gov/pubmed/37456233 http://dx.doi.org/10.3389/fonc.2023.1134646

Ejemplares similares

Multiparametric MRI combined with clinical factors to predict glypican-3 expression of hepatocellular carcinoma
por: Liu, Peijun, et al.
Publicado: (2023)

Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study
por: Ye, Zheng, et al.
Publicado: (2019)

Nomogram development and validation to predict Ki-67 expression of hepatocellular carcinoma derived from Gd-EOB-DTPA-enhanced MRI combined with T1 mapping
por: Liu, Ziwei, et al.
Publicado: (2022)

Preoperative prediction of cytokeratin-19 expression for hepatocellular carcinoma using T1 mapping on gadoxetic acid-enhanced MRI combined with diffusion-weighted imaging and clinical indicators
por: Zhao, Yue, et al.
Publicado: (2023)

Nomogram Based on CT Radiomics Features Combined With Clinical Factors to Predict Ki-67 Expression in Hepatocellular Carcinoma
por: Wu, Cuiyun, et al.
Publicado: (2022)

Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancer
por: Feng, Shuqian, et al.
Publicado: (2022)

Preoperative Gadoxetic Acid-Enhanced MRI Based Nomogram Improves Prediction of Early HCC Recurrence After Ablation Therapy
por: Hu, Chengguang, et al.
Publicado: (2021)

Degree of Resection and Ki-67 Labeling Index for Recurring Meningiomas
por: Menger, Richard, et al.
Publicado: (2017)

Evaluation of the Therapeutic Effect of Adjuvant Transcatheter Arterial Chemoembolization Based on Ki67 After Hepatocellular Carcinoma Surgery
por: Zhao, Yu-Fei, et al.
Publicado: (2021)

Intratumoral and peritumoral radiomics model based on abdominal ultrasound for predicting Ki-67 expression in patients with hepatocellular cancer
por: Qian, Hongwei, et al.
Publicado: (2023)

Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI
por: Palm, Viktoria, et al.
Publicado: (2018)

Gadoxetic acid–enhanced MRI with a focus on LI-RADS v2018 imaging features predicts the prognosis after radiofrequency ablation in small hepatocellular carcinoma
por: Wang, Ruizhi, et al.
Publicado: (2023)

Combined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients
por: Hao, Junmei, et al.
Publicado: (2021)

Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma
por: Fan, Yanfen, et al.
Publicado: (2021)

The expression of Ki-67 and Glypican -3 in hepatocellular carcinoma was evaluated by comparing DWI and (18)F-FDG PET/CT
por: Wang, Xuedong, et al.
Publicado: (2023)

Prognostic and Clinicopathological Value of Ki-67 in Melanoma: A Meta-Analysis
por: Liu, Qixin, et al.
Publicado: (2021)

Value of T1 mapping on gadoxetic acid-enhanced MRI for microvascular invasion of hepatocellular carcinoma: a retrospective study
por: Rao, Chenyi, et al.
Publicado: (2020)

Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma
por: Ricke, Jens, et al.
Publicado: (2020)

Preoperative prediction of Ki-67 and p53 status in meningioma using a multiparametric MRI-based clinical-radiomic model
por: Moon, Chung-Man, et al.
Publicado: (2023)

Benign nodules mimicking hepatocellular carcinoma on gadoxetic acid-enhanced liver MRI
por: Song, Kyoung Doo, et al.
Publicado: (2015)

Multiple directional DWI combined with T2WI in predicting muscle layer and Ki‐67 correlation in bladder cancer in 3.0‐T MRI
por: Zhang, Wei, et al.
Publicado: (2023)

Ki-67 and Its Relation With Complete Pathological Response in Patients With Breast Cancer
por: Wajid, Sana, et al.
Publicado: (2021)

Predictive Value of Combined Preoperative Carcinoembryonic Antigen Level and Ki-67 Index in Patients With Gastric Neuroendocrine Carcinoma After Radical Surgery
por: Xie, Jianwei, et al.
Publicado: (2021)

The prognostic index PRIMA-PI combined with Ki67 as a better predictor of progression of disease within 24 months in follicular lymphoma
por: Hu, Jiaci, et al.
Publicado: (2023)

CT Radiomics Model for Predicting the Ki-67 Index of Lung Cancer： An Exploratory Study
por: Fu, Qing, et al.
Publicado: (2021)

Relationship Between Ultrasound Features and Ki-67 Labeling Index of Soft Tissue Sarcoma
por: Wang, Pingping, et al.
Publicado: (2021)

Differentiation of Small Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Liver: Texture Analysis Based on MRI Improved Performance in Comparison Over Gadoxetic Acid-Enhanced MR and Diffusion-Weighted Imaging
por: Zhong, Xi, et al.
Publicado: (2020)

Based on clinical Ki-67 expression and serum infiltrating lymphocytes related nomogram for predicting the diagnosis of glioma-grading
por: Zhang, Zhi, et al.
Publicado: (2022)

Proliferation Marker Ki67 as a Stratification Index of Adjuvant Chemotherapy for Resectable Mucosal Melanoma
por: Tang, Lirui, et al.
Publicado: (2022)

Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy
por: Kim, Ji-Yeon, et al.
Publicado: (2022)

A radiomics model based on preoperative gadoxetic acid–enhanced magnetic resonance imaging for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma
por: Li, Changfeng, et al.
Publicado: (2023)

Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis
por: Wu, Qiang, et al.
Publicado: (2019)

Quantification of liver function using gadoxetic acid-enhanced MRI
por: Poetter-Lang, Sarah, et al.
Publicado: (2020)

The imaging findings of Peliosis hepatis on gadoxetic acid enhanced MRI
por: Yoshida, Morikatsu, et al.
Publicado: (2020)

Value of gadoxetic acid-enhanced MRI for microvascular invasion of small hepatocellular carcinoma: a retrospective study
por: Zhou, Meng, et al.
Publicado: (2021)

Predicting microvascular invasion in hepatocellular carcinoma: A dual‐institution study on gadoxetate disodium‐enhanced MRI
por: Jiang, Hanyu, et al.
Publicado: (2022)

Predicting histologic differentiation of solitary hepatocellular carcinoma up to 5 cm on gadoxetate disodium-enhanced MRI
por: Yang, Ting, et al.
Publicado: (2023)

CT Radiomics for the Preoperative Prediction of Ki67 Index in Gastrointestinal Stromal Tumors: A Multi-Center Study
por: Zhao, Yilei, et al.
Publicado: (2021)

A Nomogram for Preoperatively Predicting the Ki-67 Index of a Pituitary Tumor: A Retrospective Cohort Study
por: Cai, Xiangming, et al.
Publicado: (2021)

Utility of KI-67 as a prognostic biomarker in pulmonary neuroendocrine neoplasms: a systematic review and meta-analysis
por: Naheed, Salma, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9e188f2o2shmqgf9bgpd755q22